BIA Separations

Activities: Manufacturing

Trending Articles

  1. Manufacturing Chemist Stand Side with Olon Spa We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!
  2. Novel innovation enhances productivity and output for Polish pharma company A consultative approach to service, delivery and problem solving ensured that a Polish pharmaceutical company received the equipment and technology it needed to ramp up...
  3. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  4. PTC Therapeutics' gene therapy Kebilidi bags FDA approval for AADC deficiency The gene therapy is the first to be approved in the US for direct administration to the brain, and tackles aromatic L-amino acid decarboxylase deficiency (AADC)
  5. Adragos Pharma enhances its sterile injectable production capabilities with new €13m ampoule filling line The novel line at the CDMO's Livron-sur-Drôme site in France will allow the company to manufacture more than 160 million ampoules for sterile injectables annually

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Distribution

BIA Separations signs two new distribution agreements extending coverage in Asia Pacific

GeneX India Biosciences has taken over sole distribution activities in India, while IT Technologies will operate in Singapore and Malaysia
Manufacturing

BIA to commercialise novel elution method for viral vector purification

University of Zagreb in Coratia has signed an agreement to commercialise new method that helps preserve viruses during immunoaffinity purification
Research & Development

AveXis chooses BIA Separations to support gene therapy pipeline

BIA Separations will provide the Novartis company expertise in next-gen biomolecule purification processes and CIMmultus monolithic columns
Manufacturing

BIA Separations builds new upstream processing facility

The expansion will provide a single source of expertise for scaled up production of complex biologics for gene therapy and vaccines
Manufacturing

Conference to showcase UK strength in medicines manufacturing

GlaxoSmithKline will open its doors at its site in Stevenage, to host the Medicines Manufacturing Industry Partnership Annual Conference 2018, taking place 7 June
Manufacturing

BIA Separations and Biomay collaborate on production and purification of large DNA plasmids

The collaboration enables high yield, high purity supercoiled plasmid DNA manufacture for therapeutic application
Manufacturing

BIA Separations and Nuvonis Technologies partner

The agreement between the two companies will aim to strengthen upstream and downstream process development in vaccine and gene therapy production
Subscribe now